Literature DB >> 7728760

Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers.

S L Peiffer1, T J Herzog, D J Tribune, D G Mutch, D J Gersell, P J Goodfellow.   

Abstract

Thirty-seven endometrial cancers were subjected to an allelotype analysis in an attempt to identify chromosomal regions that are lost in a significant portion of tumors and to identify tumors characterized by replication errors. Thirty-nine highly polymorphic microsatellite markers representing all chromosomal arms, excluding the X and the short arms of the acrocentrics, were examined. An average of 20 informative cases were evaluated for each marker. Genetic alterations were detected in 30 of the 37 tumors. Replication errors were identified in 8 tumor specimens. Loss of heterozygosity was observed for loci on all chromosomes examined with the exception of chromosomes 4 and 20. The two most frequent sites of loss were at the marker loci examined on 10q (40%) and 17p (29%). Six additional simple sequence repeat markers from 10q were genotyped in an effort to refine the region of 10q loss. The chromosome 10 markers used in these studies were physically mapped with the use of a panel of somatic hybrids that retain defined portions of chromosome 10. The observed patterns of loss of sequences on 10q suggest a role for a tumor suppressor gene in the 10q23-26 region in the development or progression of endometrial cancers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728760

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Lower uterine segment involvement is associated with poor outcomes in early-stage endometrioid endometrial carcinoma.

Authors:  Nora T Kizer; Feng Gao; Saketh Guntupalli; Premal H Thaker; Matthew A Powell; Paul J Goodfellow; David G Mutch; Israel Zighelboim
Journal:  Ann Surg Oncol       Date:  2010-12-22       Impact factor: 5.344

2.  miR-202 suppresses proliferation and induces apoptosis of osteosarcoma cells by downregulating Gli2.

Authors:  Zhengwen Sun; Tongqing Zhang; Huanyu Hong; Qingxia Liu; Haiguang Zhang
Journal:  Mol Cell Biochem       Date:  2014-08-26       Impact factor: 3.396

3.  Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q.

Authors:  R Albarosa; B M Colombo; L Roz; I Magnani; B Pollo; N Cirenei; C Giani; A M Conti; S DiDonato; G Finocchiaro
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

4.  A Drosophila model of multiple endocrine neoplasia type 2.

Authors:  Renee D Read; Paul J Goodfellow; Elaine R Mardis; Nancy Novak; Jon R Armstrong; Ross L Cagan
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

5.  CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.

Authors:  Judit Pallares; David Llobet; Maria Santacana; Nuria Eritja; Ana Velasco; Dolors Cuevas; Susana Lopez; Victor Palomar-Asenjo; Andree Yeramian; Xavier Dolcet; Xavier Matias-Guiu
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

6.  Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26.

Authors:  Susan A Treloar; Jacqueline Wicks; Dale R Nyholt; Grant W Montgomery; Melanie Bahlo; Vicki Smith; Gary Dawson; Ian J Mackay; Daniel E Weeks; Simon T Bennett; Alisoun Carey; Kelly R Ewen-White; David L Duffy; Daniel T O'connor; David H Barlow; Nicholas G Martin; Stephen H Kennedy
Journal:  Am J Hum Genet       Date:  2005-07-21       Impact factor: 11.025

7.  K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis.

Authors:  G L Mutter; H Wada; W C Faquin; T Enomoto
Journal:  Mol Pathol       Date:  1999-10

8.  Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.

Authors:  Paul J Goodfellow; Barbara M Buttin; Thomas J Herzog; Janet S Rader; Randall K Gibb; Elizabeth Swisher; Katherine Look; Ken C Walls; Ming-Yu Fan; David G Mutch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

9.  PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice.

Authors:  Cong Peng; Yaoyu Chen; Zhongfa Yang; Haojian Zhang; Lori Osterby; Alan G Rosmarin; Shaoguang Li
Journal:  Blood       Date:  2009-11-18       Impact factor: 22.113

10.  The genomics and genetics of endometrial cancer.

Authors:  Andrea J O'Hara; Daphne W Bell
Journal:  Adv Genomics Genet       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.